Low-power extracorporeal shock wave therapy for improvement of blood pressure and suppression of renal function reduction in CKD patients diagnosed as chronic kidney disease (CKD) stage 3, 4

Low-power extracorporeal shock wave therapy for improvement of blood pressure and suppression of renal function reduction in CKD patients diagnosed as chronic kidney disease (CKD) stage 3, 4 - ESWT-CKD

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000030448

Enrollment

Registered

2019-04-01

Start date

2018-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CKD stage 3 &amp

Interventions

Extracorporeal Shock Wave control

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: CKD stage 3 & 4 patients with at least one history of hypertension, diabetes, dyslipidemia, smoking history, cardiovascular complications

Exclusion criteria

Exclusion criteria: Patients with a local skin infection at the contact site with the applicator Patients with bleeding tendency Patients with urolithiasis or kidney stones Patients with hydronephrosis Patients with active pyelonephritis Patients with cancer Patients treated with steroids or immunosuppressants Patients who is expected to introduce dialysis within 12 weeks Polycystic kidney disease patients Patients with renal morphological abnormality Patients who received kidney transplantation Dialysis patients (HD, PD) Patients whose renal blood flow cannot be evaluated Objects considered by the attending physician as inappropriate

Design outcomes

Primary

Measure	Time frame
improvement of mean blood pressure	—

Secondary

Measure	Time frame
improvement of eGFR	—

Countries

Japan

Contacts

Public ContactYoshitaka Isaka

Osaka University Graduate School of Medicine Nephrology

isaka@kid.med.osaka-u.ac.jp0668793857

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026